Loading...
•
Dec 31, 2019
Humana Q4 2019 Earnings Report
Humana reported strong Q4 2019 financial results, exceeding expectations with growth in Medicare Advantage and strategic investments.
Key Takeaways
Humana's Q4 2019 earnings exceeded expectations, driven by strong performance in the Medicare Advantage business and Healthcare Services segment. The company reported a GAAP EPS of $3.84 and an adjusted EPS of $2.28. Revenues for the quarter were $16.295 billion. The company also provided FY 2020 EPS guidance in a range of $17.76 to $18.26 on a GAAP basis, $18.25 to $18.75 on an Adjusted basis.
Q4 2019 GAAP EPS was $3.84, and adjusted EPS was $2.28.
FY 2019 GAAP EPS was $20.10, and adjusted EPS was $17.87, exceeding previous guidance.
FY 2020 EPS guidance is projected to be in the range of $17.76 to $18.26 on a GAAP basis, and $18.25 to $18.75 on an adjusted basis.
The retail segment finished the year strong, with the segment benefit expense ratio 70 basis points better than the initial guidance midpoint.
Humana
Humana
Forward Guidance
Humana provided its GAAP and Adjusted EPS guidance for the year ending December 31, 2020 (FY 2020).
Positive Outlook
- Positive momentum from strong 2019 results
- Industry-leading individual Medicare Advantage membership growth
- Seniors are increasingly choosing Medicare Advantage plans
- Humana’s value proposition, consumer orientation and strong brand resonate in the market
- Expect 2020 to be another good year for the company with solid top and bottom line growth notwithstanding the return of the health insurance industry fee